NCCN task force report: management of neuropathy in cancer
- PMID: 19755042
- DOI: 10.6004/jnccn.2009.0078
NCCN task force report: management of neuropathy in cancer
Abstract
Neuropathy is a common, often debilitating complication of cancer and its treatment. Effective management of this disorder depends on early diagnosis and an understanding of its underlying causes in the individual patient. In January 2009, NCCN gathered a multidisciplinary group to review the literature and discuss intervention strategies currently available to patients as well as areas that require research efforts. The task force, which comprised experts in anesthesiology, medical oncology, neurology, neuro-oncology, neurophysiology, nursing, pain management, and rehabilitation, was charged with the goal of outlining recommendations for the possible prevention, diagnosis, and management of neuropathy. This report documents the proceedings of this meeting with a general background on neuropathy and neuropathy in oncology, followed by discussions on challenges and research issues, evaluation criteria, and management of different symptoms associated with this disorder.
Similar articles
-
Chemotherapy-induced peripheral neuropathy in pediatric cancer patients.Semin Pediatr Neurol. 2012 Mar;19(1):9-17. doi: 10.1016/j.spen.2012.02.011. Semin Pediatr Neurol. 2012. PMID: 22641071 Review.
-
Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain.J Clin Oncol. 2012 Oct 20;30(30):3687-96. doi: 10.1200/JCO.2012.41.7238. Epub 2012 Sep 24. J Clin Oncol. 2012. PMID: 23008320 Review.
-
Information for patients. Peripheral neuropathy and cancer.Oncology (Williston Park). 2008 Apr;22(4 Suppl Nurse Ed):40a-40b. Oncology (Williston Park). 2008. PMID: 19856562 English, Spanish. No abstract available.
-
Oxaliplatin induced-neuropathy in digestive tumors.Crit Rev Oncol Hematol. 2014 Jan;89(1):166-78. doi: 10.1016/j.critrevonc.2013.08.009. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2014. PMID: 24029604 Review.
-
Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness.Am Soc Clin Oncol Educ Book. 2018 May 23;38:469-479. doi: 10.1200/EDBK_209437. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231411 Review.
Cited by
-
Factors Influencing Lower Urinary Tract Symptoms in Advanced Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy.Int Neurourol J. 2018 Sep;22(3):192-199. doi: 10.5213/inj.1836084.042. Epub 2018 Sep 28. Int Neurourol J. 2018. PMID: 30286582 Free PMC article.
-
Effect of Physical Activity on Static and Dynamic Postural Balance in Women Treated for Breast Cancer: A Systematic Review.Int J Environ Res Public Health. 2023 Feb 20;20(4):3722. doi: 10.3390/ijerph20043722. Int J Environ Res Public Health. 2023. PMID: 36834417 Free PMC article.
-
Inhibition of Soluble Epoxide Hydrolase Prevents Docetaxel-Induced Painful Peripheral Neuropathy.Int J Mol Sci. 2025 Jun 12;26(12):5630. doi: 10.3390/ijms26125630. Int J Mol Sci. 2025. PMID: 40565091 Free PMC article.
-
Effect of Acupuncture in Pain Management of Head and Neck Cancer Radiotherapy: Prospective Randomized Unicentric Study.J Clin Med. 2021 Mar 7;10(5):1111. doi: 10.3390/jcm10051111. J Clin Med. 2021. PMID: 33799949 Free PMC article.
-
Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.Qual Life Res. 2013 Dec;22(10):2787-99. doi: 10.1007/s11136-013-0379-8. Epub 2013 Mar 30. Qual Life Res. 2013. PMID: 23543373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
